Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 1, 1996, Pages 199-204

  Lishner, Michael ^a,b   Confino Cohen, Ronit ^a,b   Mekori, Yoseph A ^a,b   Feigin, Moshe ^a   Manor, Yoseph ^a,b   Goldberg, Arnon ^a,b   Ravid, Mordechai ^a,b   Amiel, Aliza ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

fluorescent in situ hybridization; myeloproliferative disorders; systemic mastocytosis; trisomy 8; trisomy 9

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; CHROMOSOME 9; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE DEFICIENCY; IN SITU HYBRIDIZATION; KARYOTYPE; MALE; MAST CELL; MASTOCYTOSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; TRISOMY 8;

EID: 0029781403     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70243-9     Document Type: Article

References (45)

1. Travis WD, Li C-Y, Yam LT, Bergstralh EJ, Swee RG. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-68.
2. Metcalfe DD. Mastocytosis. In: Wyngaarden JB, Smith LH, Bennet JC, eds. Cecil textbook of medicine. Philadelphia: Saunders, 1992:1483-5.
3. Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985;16:808-14.
4. Kirshenbaum AS, Rottem M, Metcalfe DD, Goff JP. The origin and development of murine and human mast cells. In: The mast cell in health and disease. Kaliner MA, Metcalfe DD, eds. New York: Marcel Dekker, 1993:203-17.
5. Razin E, Ihle JN, Seldin D, et al. Interleukin-3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 1984;132:1479-86.
6. Anderson DM, Lyman SD, Baird A, et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 1990;63:235-43.
7. Nocka K, Buck J, Levi J, Besmer P. Candidate ligand for the c-kit transmembrane kinase receptor. KL, a fibroblast derived growth factor stimulates mast cell and erythroid progenitors. EMBO J 1990;9:3287-91.
8. Kirshenbaum AS, Goff JP, Dreskin SC, Irani AM, Schwartz LB, Metcalfe DD. IL-3-dependent growth of basophil-like cells and mast like cells from human bone marrow. J Immunol 1989;142:2424-9.
9. Mekori YA, Oh CK, Metcalfe DD. IL-3 dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by C-kit ligand. J Immunol 1993;151:3775-84.
10. Tsai M, Takashi T, Thompson H, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991;88:6382-6.
11. + bone marrow progenitor cells. J Immunol 1991;146:1410-5.
12. Agis H, Wellheim M, Sperr WR, et al. Monocytes do not make mast cells when cultured in the presence of SCF. J Immunol 1993;151:4221-7.
13. Nagata H, Worobec A, Oh C, Suzuki Y, Metcalfe DD. Identification of a point mutation of the proto-oncogene c-kit in patients with mastocytosis [Abstract]. J Allergy Clin Immunol 1995;95:176.
14. Cooper AJ, Winkelmann RK, Wiltsie JC. Hematologic malignancies occurring in patients with urticaria pigmentosa. J Am Acad Dermatol 1982;7:125-9.
15. Travis WD, Chin Yang Li, Lung TY, Bergstrale EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988;6:965-72.
16. Swolin B, Rodjer S, Roupe G. Cytogenetic studies and in vitro colony growth in patients with mastocytosis. Blood 1987;70:1928-32.
17. Yam LT, Yam CF, Li CY. Eosinophilia in systemic mastocytosis. Am J Clin Pathol 1980;73:48-54.
18. Rege-Cambrin G, Mecucci C, Tricot G, et al. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 1987;25:233-45.
19. Diez-Martin JL, Graham DL, Petitt RM, Dewald GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc 1991;66:287-99.
20. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-8.
21. Kibbelaar RE, Mulder JWR, Dreef EJ, et al. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescent in situ hybridization. Blood 1993;82:904-13.
22. Amiel A, Gaber E, Manor Y, et al. Fluorescence in situ hybridization for the detection of trisomy 8 and 9 in polycythemia vera patients. Cancer Genet Cytogenet 1995;79:153-6.
23. Jankins RB, LaBeau M, Kraker WJ, et al. Fluorescent in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 1992;79:3307-15.
24. Lidor C, Frisch B, Gazit D, Gepstein R, Hallel T, Mekori YA. Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res 1990;5:871-6.
25. Westin J, Whalstrom J, Swoling B. Chromosome studies in untreated polycythemia vera. Scan J Hematol 1976;17:183-96.
26. Swolin B, Weinfeld A, Westin J. A prospective long term Cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 1988;72:386-95.
27. Bagby GC. The preleukemic syndrome. Blood 1988;2:194-205.
28. Hagenmeijer A. Chromosome abnormalities in CML. In: Goldman JM, ed. Baillier's clinical hematology. Chronic myeloid leukemia. London: Bailliere Tindall, 1987:963-81.
29. Smith RE, Chelmowski MK, Szabo EJ. Myelofibrosis: a concise review of clinical and pathologic features and treatment. Am J Hematol 1988;29:174-80.
30. Parker RI. Hematologic aspects of mastocytosis. II. Management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 1991;96:52S-54S.
31. Horny HP, Ruck M, Wehrman M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of simultaneous occurrence of myeloproliferative disorders. Br J Haematol 1990;76:186-93.
32. Lewis TP, Welborn JL, Meyers FJ, Levy NB, Roschak T. Mast cell disease followed by leukemia with clonal evolution. Cancer Res 1987;11:769-73.
33. Horton MA, O'Brien HAW. Characterization of human mast cells in long term cultures. Blood 1983;62:1251-4.
34. Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophil/mast cell precursors in human peripheral blood. Blood 1983;61:775-80.
35. Lennert K, Parwaresch MR. Mast cells and mast cell neoplasia: a review. Histopathology 1979;3:349-63.
36. Sagher F, Liban E, Ungar H, et al. Urticaria pigmentosa with bone involvement, mast cell aggregates in bone and myelosclerosis found at autopsy in a case dying of monocytic leukemia. J Invest Dermatol 1956;27:355-68.
37. Cains LJ. Systemic mastocytosis: Aust J Dermatol 1972;13:111-3.
38. Gisslinger H, Linkesch W, Fritz E, Ludwig H, Chott A, Radaszkiewicz TH. Long term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet 1989;1:634-7.
39. Kloke O, Niederle N, Qiu JY, et al. Impact of interferon alpha induced cytogenetic improvement on survival in chronic myelogenous leukemia. Br J Haematol 1993;83:399-403.
40. Kluin-Nelemans HC, Jansen JP, Breukelmau H, et al. Response to interferon alpha-2b in a patient with systemic mastocytosis. N Engl J Med 1992;326:619-23.
41. Strife A, Clarkson B. Biology of chronic myelogenous leukemia: Is discordant moturation the primary defect? Semin Hematol 1988;25:1-19.
42. Lalkin A, Lishner M, Gaber M, et al. In situ hybridization: a simple and sensitive method for the detection of trisomy 12 in chronic lymphocytic leukemia. Can Genet Cytogenet 1993;70:21-4.
43. Autio K, Elonen E, Teerenhovi L, Knuutila S. Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukemia. Eur J Hematol 1990;39:289-294.
44. Bird ML, Ueshina Y, Rowley JD, Haren JM, Vardiman JW. Chromosomal abnormalities in B-cell chronic lymphocytic leukemia and their clinical correlations. Leukemia 1989;3:182-91.
45. Nederlof PM, Van der Flier S, Raap AK, et al. Detection of chromosome aberrations in interphase tumor nuclei by non-radioactive in situ hybridization. Cancer Genet Cytogenet 1989;42:87-98.